Johnston B L
Heart Lung. 1984 Jan;13(1):18-27.
Data from the preceding low-level exercise test studies have been compiled and are presented in Table II. The table is arranged according to groups of prognostic indicators for future coronary events or indicators for those patients with multivessel coronary artery disease. In summary, current studies demonstrate safety and predictive value in predischarge low-level exercise testing in patients after myocardial infarction. If the test reveals a positive S-T segment change or angina or both, the predictive value for future cardiac events is significant. In addition, a limited duration on the exercise test, a flat or falling blood pressure response, and the presence or absence of premature ventricular depolarizations add to this predictive value. A more sophisticated technique that employs radionuclide ventriculography may add to the sensitivity and specificity of these various tests but should be used selectively. Post-myocardial infarction patients who perform low-level exercise testing prior to discharge and demonstrate no exercise-induced abnormality from baseline may also harbor multivessel coronary disease, and this group of patients needs to be carefully followed. Testing at 3 weeks and 6 weeks after infarction may be beneficial in revealing additional clinical data. Less data are currently available on predischarge low-level exercise testing in patients with myocardial revascularization. However, these limited data support both feasibility and safety of low-level exercise testing in myocardial revascularization patients before discharge. Prognostic data with regard to low-level exercise testing for this group of patients should be forthcoming. Data from low-level exercise testing need to be incorporated during the in-hospital phase to eliminate unnecessary testing as the patient proceeds home and/or to medically supervised exercise programs. Proper therapeutic modalities based on these data should be included. In accord with this, it is imperative that the cardiac rehabilitation team or exercise testing laboratory correspond directly with the private physician regarding all clinical data and recommendations for discharge activity. Follow-up exercise testing for patients after myocardial infarction and coronary bypass surgery utilizes end points similar to those of predischarge low-level testing and therefore will not be discussed in detail. In general the patient should be able to achieve a higher heart rate or MET level in follow-up testing.(ABSTRACT TRUNCATED AT 400 WORDS)
先前低水平运动试验研究的数据已汇总并列于表二。该表是根据未来冠心病事件的预后指标组或多支冠状动脉疾病患者的指标进行排列的。总之,目前的研究表明,心肌梗死后患者出院前进行低水平运动试验具有安全性和预测价值。如果试验显示S-T段改变阳性或心绞痛或两者皆有,那么对未来心脏事件的预测价值就很显著。此外,运动试验持续时间有限、血压反应平稳或下降以及室性早搏的有无也增加了这种预测价值。采用放射性核素心室造影的更复杂技术可能会提高这些不同试验的敏感性和特异性,但应选择性使用。在出院前进行低水平运动试验且未显示出与基线相比有运动诱发异常的心肌梗死后患者,也可能患有多支冠状动脉疾病,这组患者需要密切随访。在心肌梗死后3周和6周进行试验可能有助于揭示更多临床数据。目前关于心肌血运重建患者出院前低水平运动试验的数据较少。然而,这些有限的数据支持了心肌血运重建患者出院前进行低水平运动试验的可行性和安全性。关于这组患者低水平运动试验的预后数据即将公布。在住院期间应纳入低水平运动试验的数据,以便在患者回家和/或参加医学监督的运动计划时消除不必要的检查。应根据这些数据纳入适当的治疗方式。据此,心脏康复团队或运动试验实验室必须就所有临床数据和出院活动建议直接与私人医生沟通。心肌梗死和冠状动脉搭桥手术后患者的随访运动试验使用的终点与出院前低水平试验相似,因此不再详细讨论。一般来说,患者在随访试验中应能够达到更高的心率或代谢当量水平。(摘要截选至400字)